FDA progress for GraftAssureDx, registry momentum, launch timing, and cash burn outlook—read the key takeaways now.

Researchers at the University of Pennsylvania have developed ApexGO, a novel, AI-powered method for turning promising but imperfect antibiotic candidates into more potent ones. Unlike many existing AI ...

Many drug and antibody discovery pathways focus on intricately folded cell membrane proteins. When molecules of a drug ...

Perth biotech Syngenis is using AI to slash the time and cost of discovering RNA therapies, targeting a booming global market ...

Today Microsoft is announcing a major step forward in AI-powered cyber defense: a new multi-model agentic scanning harness ...

Spatial-biology tools are collecting more comprehensive data, and companies that want to model cells in silico are hoovering ...

TrilliumBiO, a leader in biomarker discovery and precision diagnostics, and Oncobit, a Swiss precision oncology company, ...

The 2026 AI 100 list emphasizes early growth and market validation, the surge of financial services-focused AI, the ...

Reply to: Yttrium-90 Radioembolization Provides Durable Local Control and Definitive Radiation Therapy Chronic myelomonocytic leukemia (CMML) is a rare myeloid neoplasm characterized by clinical ...

Launch, Ascent, and Vehicle Aerodynamics (LAVA) is the tool NASA uses to model reentry, aerodynamics, and fluid dynamics for Mars landers and the SLS (Space Launch System) that launched Artemis II.

In the wake of Anthropic’s announcement of its latest artificial intelligence model, Mythos, on April 7, the company has stood by an unusual decision: refusing to release it to the public. Not since ...